Brilact 10 mg (Brivaracetam)

Adult dose

This product is taken twice daily. The recommended initial dose is 25mg or 50mg per dose, based on the healthcare professional's assessment of potential adverse effects relative to seizure reduction. Based on clinical response and tolerability, the dose may be increased or decreased from 50mg daily [25mg twice daily] to 200mg daily [100mg twice daily]. Take this product as a whole film-coated tablet with water. It may be taken with or without food. If you miss a dose If you miss one or more doses, take one dose as soon as you remember, then take the next dose at the next scheduled morning or evening time. Discontinuation If you wish to discontinue this product, gradually reduce the dose by 50mg daily at 1-week intervals. After taking 50mg daily for 1 week, a dose of 20mg daily is recommended during the final week (see section '1. Warnings'). Older adults (65 years or older) No dosage adjustment is necessary for older adults. Clinical experience in older patients aged 65 years or older is limited. Renal impairment No dosage adjustment is necessary for patients with renal impairment. This product is not recommended for patients with end-stage renal disease undergoing hemodialysis. Hepatic impairment Exposure to this product is increased in patients with hepatic impairment. An initial dose of 50mg daily [25mg twice daily] is recommended for patients with hepatic impairment, and a maximum dose of 150mg daily [75mg twice daily] is recommended.

This medication, used for the treatment of epilepsy, may slightly increase the risk of mental health issues such as suicidal thoughts or behaviors, so careful observation for these symptoms is necessary. Additionally, central nervous system-related side effects such as drowsiness, fatigue, and dizziness may frequently occur, so caution should be exercised if these symptoms arise. Abrupt discontinuation of this medication may increase the frequency of seizures, so dosage should be gradually reduced under the supervision of a healthcare provider. Individuals allergic to the active ingredient or any components of this medication should not take it, and it should also not be administered to those with hereditary lactose intolerance. Patients with impaired liver function may need dosage adjustment, so they should consult their physician if they have liver impairment. During treatment, skin rash or severe allergic reactions may occur, so any unusual skin symptoms should be reported to medical staff immediately. This medication may interact with other antiepileptic drugs or certain medications, so if you are taking other drugs, inform your physician or pharmacist. Pregnant or breastfeeding women should consult a doctor before taking this medication, and it is important for women of childbearing age to discuss appropriate contraceptive methods. Caution is required when using this medication in children under 16, as safety and efficacy have not been established. Drowsiness or dizziness may occur when taking this medication, so it is advisable to avoid activities requiring alertness like driving or operating machinery until symptoms completely resolve. In case of overdose, symptoms such as drowsiness, dizziness, anxiety, and depression may appear, and as there is no specific antidote, immediate medical attention should be sought in emergency situations. Store this medication out of reach of children and do not transfer it to other containers to ensure safety and quality maintenance.

• suicidal thoughts
• suicidal behavior
• drowsiness
• fatigue
• dizziness
• coordination disorders
• influenza
• type I hypersensitivity
• neutropenia
• decreased appetite

This medication should be stored in a closed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1°C and 30°C.

Appearance

White round film-coated tablet

Package unit

60 tablets/PTP [10 tablets/PTP x 6]